FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Losartan potassium 50 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 each gastro-resistant oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely venlafaxine 37.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False un Inferred relationship Some
    Fenbufen 450 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Thioridazine hydrochloride 200 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Morphine sulfate 50 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Tetracycline 500 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial Has presentation strength numerator value False un Inferred relationship Some 1
    Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely activated charcoal 5 gram/1 sachet conventional release oral granules (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Aciclovir (as aciclovir sodium) 250 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Agalsidase beta 5 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Agalsidase beta 5 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefradine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Cefradine 1 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Cefradine 1 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Cefradine 1 g powder for solution for injection vial Has presentation strength numerator value False un Inferred relationship Some 1
    Amphotericin B 50 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Amphotericin B 50 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Aciclovir (as aciclovir sodium) 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Dantrolene sodium 20 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Dantrolene sodium 20 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Alprostadil 20 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Alprostadil 20 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False un Inferred relationship Some 1
    ceftazidime 3 g, flacon de poudre pour solution injectable Count of base of active ingredient False un Inferred relationship Some
    ceftazidime 3 g, flacon de poudre pour solution injectable Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation Count of base of active ingredient False un Inferred relationship Some
    Alprostadil 40 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Alprostadil 40 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely doripenem (as doripenem monohydrate) 500 milligram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely doripenem (as doripenem monohydrate) 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False un Inferred relationship Some
    Alprostadil 5 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Alprostadil 5 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Alteplase 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Alteplase 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Aztreonam 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Aztreonam 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False un Inferred relationship Some 1
    Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Aztreonam 1 g powder for solution for injection vial Has presentation strength numerator value False un Inferred relationship Some 1
    Aztreonam 1 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Aztreonam 1 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 2
    Aztreonam 2 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Aztreonam 2 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Amobarbital sodium 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Amobarbital sodium 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Basiliximab 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Basiliximab 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Basiliximab 20 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Basiliximab 20 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Diamorphine hydrochloride 10 mg powder for solution for injection ampule Has presentation strength denominator value False un Inferred relationship Some 1
    Diamorphine hydrochloride 10 mg powder for solution for injection ampule Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1

    Start Previous Page 68 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start